Effects of miR-100-5p on proliferation and apoptosis of acute myeloid leukemia cells and the underlying molecular mechanism

Xiao-Ru FAN, Ying YANG, Yin SUN, Cong-Mei DU

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (1) : 99-106.

PDF(966 KB)
HTML
PDF(966 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (1) : 99-106. DOI: 10.7499/j.issn.1008-8830.2503192
EXPERIMENTAL RESEARCH

Effects of miR-100-5p on proliferation and apoptosis of acute myeloid leukemia cells and the underlying molecular mechanism

Author information +
History +

Abstract

Objective To investigate whether miR-100-5p regulates the proliferation and apoptosis of acute myeloid leukemia (AML) cells by targeting Tribbles pseudokinase 1 (TRIB1). Methods Peripheral blood was collected from 16 healthy children (control group) and 16 children with AML (AML group). HL-60 cells were divided into seven groups: blank, mimic negative control (mimic NC), miR-100-5p mimic, small interfering RNA negative control (si-NC), si-TRIB1, miR-100-5p mimic + TRIB1 overexpression plasmid negative control (OE-NC), and miR-100-5p mimic + TRIB1 overexpression plasmid (OE-TRIB1). The expression of miR-100-5p and TRIB1 mRNA in peripheral blood and HL-60 cells was detected by quantitative real-time PCR. Cell proliferation was assessed by 5-ethynyl-2'-deoxyuridine (EdU) staining and the cell counting kit-8 (CCK-8) assay (OD450). Apoptosis was analyzed by flow cytometry. Protein levels of TRIB1, proliferating cell nuclear antigen (PCNA), p53, programmed cell death protein 1 (PD-1), and programmed death-ligand 1 (PD-L1) were determined by Western blot. The targeting relationship between miR-100-5p and TRIB1 was validated by a dual-luciferase reporter assay. Results Compared with the control group, miR-100-5p expression was decreased and TRIB1 mRNA expression was increased in the peripheral blood of the AML group (P<0.05). Compared with the blank and mimic NC groups, the miR-100-5p mimic group showed higher miR-100-5p expression, apoptosis rate, and p53 protein, and lower TRIB1 mRNA expression, EdU-positive rate, OD450 value, and TRIB1, PCNA, PD-1, and PD-L1 proteins (P<0.05). Compared with the blank and si-NC groups, the si-TRIB1 group exhibited reduced TRIB1 mRNA expression, EdU-positive rate, OD450 value, and TRIB1, PCNA, PD-1, and PD-L1 proteins, together with increased apoptosis rate and p53 protein (P<0.05). Compared with the miR-100-5p mimic and miR-100-5p mimic + OE-NC groups, the miR-100-5p mimic + OE-TRIB1 group had elevated TRIB1 mRNA expression, EdU-positive rate, OD450 value, and TRIB1, PCNA, PD-1, and PD-L1 proteins, and reduced apoptosis rate and p53 protein (P<0.05). Compared with the TRIB1-WT + mimic NC group, luciferase activity was decreased in the TRIB1-WT + miR-100-5p mimic group (P<0.05). Conclusions Overexpression of miR-100-5p inhibits proliferation and induces apoptosis of HL-60 cells by downregulating TRIB1.

Key words

MiR-100-5p / Tribbles pseudokinase 1 / Acute myeloid leukemia / Proliferation / Apoptosis / HL-60 cell

Cite this article

Download Citations
Xiao-Ru FAN , Ying YANG , Yin SUN , et al. Effects of miR-100-5p on proliferation and apoptosis of acute myeloid leukemia cells and the underlying molecular mechanism[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(1): 99-106 https://doi.org/10.7499/j.issn.1008-8830.2503192

References

[1]
Zhang H, Tao Y, Ding X, et al. Roles of the hsa_circ_0013880/USP32/Rap1b axis in the proliferation and apoptosis of acute myeloid leukemia cells[J]. Acta Biochim Biophys Sin (Shanghai), 2023, 55(3): 382-393. PMCID: PMC10160239. DOI: 10.3724/abbs.2023037 .
[2]
Tseng S, Lee ME, Lin PC. A review of childhood acute myeloid leukemia: diagnosis and novel treatment[J]. Pharmaceuticals (Basel), 2023, 16(11): 1614. PMCID: PMC10674205. DOI: 10.3390/ph16111614 .
[3]
Shao X, Zhong L, Chu X, et al. ZNF460-regulated COMMD7 promotes acute myeloid leukemia proliferation via the NF-κB signaling pathway[J]. Int J Med Sci, 2023, 20(4): 520-529. PMCID: PMC10087627. DOI: 10.7150/ijms.80047 .
[4]
Rasche M, Zimmermann M, Steidel E, et al. Survival following relapse in children with acute myeloid leukemia: a report from AML-BFM and COG[J]. Cancers (Basel), 2021, 13(10): 2336. PMCID: PMC8151466. DOI: 10.3390/cancers13102336 .
[5]
Wei X, Feng Y, Fu Y, et al. miR-100-5p is upregulated in multiple myeloma and involves in the pathogenesis of multiple myeloma through targeting MTMR3[J]. Hematology, 2023, 28(1): 2196857. DOI: 10.1080/16078454.2023.2196857 .
[6]
徐婧, 刘威, 田丽, 等. miR-100-5p靶向mTOR对急性髓样白血病细胞增殖的影响[J]. 解剖科学进展, 2022, 28(5): 511-514. DOI: 10.16695/j.cnki.1006-2947.2022.05.001 .
[7]
唐燕来, 黄礼彬, 王丽娜, 等. miR-100及miR-99a影响儿童急性淋巴细胞白血病细胞增殖和凋亡的研究[J]. 中国实用儿科杂志, 2015, 30(2): 133-137. DOI: 10.7504/ek20150206014 .
[8]
Shi G, Holgersson K, Xin Z, et al. TRIB1 facilitates the proliferation and migration of ovarian cancer cells by inducing EMT progression[J]. Histol Histopathol, 2024: 18868. DOI: 10.14670/HH-18-868 . Epub ahead of print.
[9]
Yoshino S, Yokoyama T, Sunami Y, et al. Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9[J]. Blood, 2021, 137(1): 75-88. PMCID: PMC7976434. DOI: 10.1182/blood.2019004586 .
[10]
Bhushan L, Kandpal RP. EphB6 receptor modulates micro RNA profile of breast carcinoma cells[J]. PLoS One, 2011, 6(7): e22484. PMCID: PMC3139643. DOI: 10.1371/journal.pone.0022484 .
[11]
Du F, Jin T, Wang L. Mechanism of action of decitabine in the treatment of acute myeloid leukemia by regulating LINC00599[J]. Anal Cell Pathol (Amst), 2023, 2023: 2951519. PMCID: PMC9977558. DOI: 10.1155/2023/2951519 .
[12]
Huang Z, Shen Y, Fan X, et al. Yinzhihuang injection induces apoptosis and suppresses tumor growth in acute myeloid leukemia cells[J]. PLoS One, 2023, 18(10): e0289697. PMCID: PMC10564230. DOI: 10.1371/journal.pone.0289697 .
[13]
Ghazaryan A, Wallace JA, Tang WW, et al. miRNA-1 promotes acute myeloid leukemia cell pathogenesis through metabolic regulation[J]. Front Genet, 2023, 14: 1192799. PMCID: PMC10203238. DOI: 10.3389/fgene.2023.1192799 .
[14]
Li X, Ren Y, Liu D, et al. Role of miR-100-5p and CDC25A in breast carcinoma cells[J]. PeerJ, 2022, 9: e12263. PMCID: PMC8734459. DOI: 10.7717/peerj.12263 .
[15]
Ma P, Han J. Overexpression of miR-100-5p inhibits papillary thyroid cancer progression via targeting FZD8[J]. Open Med (Wars), 2022, 17(1): 1172-1182. PMCID: PMC9263890. DOI: 10.1515/med-2022-0490 .
[16]
Zhang H, Yang K, Ren T, et al. miR-100-5p inhibits malignant behavior of chordoma cells by targeting IGF1R[J]. Cancer Manag Res, 2020, 12: 4129-4137. PMCID: PMC7293400. DOI: 10.2147/CMAR.S252185 .
[17]
Li XJ, Luo XQ, Han BW, et al. MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways[J]. Br J Cancer, 2013, 109(8): 2189-2198. PMCID: PMC3798962. DOI: 10.1038/bjc.2013.562 .
[18]
Yuan Z, Georgescu R, Yao NY, et al. Mechanism of PCNA loading by Ctf18-RFC for leading-strand DNA synthesis[J]. Science, 2024, 385(6708): eadk5901. PMCID: PMC11349045. DOI: 10.1126/science.adk5901 .
[19]
Zhao Y, Ma R, Wang C, et al. CAPG interference induces apoptosis and ferroptosis in colorectal cancer cells through the P53 pathway[J]. Mol Cell Probes, 2023, 71: 101919. DOI: 10.1016/j.mcp.2023.101919 .
[20]
Wang X, He Y, Mackowiak B, et al. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases[J]. Gut, 2021, 70(4): 784-795. DOI: 10.1136/gutjnl-2020-322526 .
[21]
Li M, Xiao Y, Liu M, et al. MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell[J]. BMC Cancer, 2022, 22(1): 876. PMCID: PMC9367141. DOI: 10.1186/s12885-022-09970-x .
[22]
Kim T, Johnston J, Castillo-Lluva S, et al. TRIB1 regulates tumor growth via controlling tumor-associated macrophage phenotypes and is associated with breast cancer survival and treatment response[J]. Theranostics, 2022, 12(8): 3584-3600. PMCID: PMC9131267. DOI: 10.7150/thno.72192 .
[23]
Yoshino S, Tanaka M, Sunami Y, et al. Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome[J]. Leukemia, 2022, 36(2): 558-561. DOI: 10.1038/s41375-021-01384-1 .
[24]
Zhang LJ, Wang F, Qi PY, et al. miR-513b-5p inhibits the proliferation and promotes apoptosis of retinoblastoma cells by targeting TRIB1[J]. Open Med (Wars), 2021, 16(1): 1364-1371. PMCID: PMC8435558. DOI: 10.1515/med-2021-0343 .
[25]
Lin X, Kang K, Chen P, et al. Regulatory mechanisms of PD-1/PD-L1 in cancers[J]. Mol Cancer, 2024, 23(1): 108. PMCID: PMC11102195. DOI: 10.1186/s12943-024-02023-w .
[26]
McClory SE, Bardhan O, Rome KS, et al. The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR+ CD8+ effector state, and its deletion improves checkpoint blockade[J]. Cell Rep, 2023, 42(8): 112905. PMCID: PMC10540077. DOI: 10.1016/j.celrep.2023.112905 .
[27]
Yokoyama T, Kanno Y, Yamazaki Y, et al. Trib1 links the MEK1/ERK pathway in myeloid leukemogenesis[J]. Blood, 2010, 116(15): 2768-2775. DOI: 10.1182/blood-2009-10-246264 .

Footnotes

所有作者声明无利益冲突。

PDF(966 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/